Andreucci MV - Search Results

1

[Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].

Cianciaruso B, Pisani A, Andreucci MV, Parente N, Andria G, Federico S, Sabbatini M, Sessa A. Cianciaruso B, et al. Among authors: andreucci mv. G Ital Nefrol. 2003 Mar-Apr;20(2):113-9. G Ital Nefrol. 2003. PMID: 12746795 Review. Italian.

2

Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.

Spinelli L, Pisani A, Sabbatini M, Petretta M, Andreucci MV, Procaccini D, Lo Surdo N, Federico S, Cianciaruso B. Spinelli L, et al. Among authors: andreucci mv. Clin Genet. 2004 Aug;66(2):158-65. doi: 10.1111/j.1399-0004.2004.00284.x. Clin Genet. 2004. PMID: 15253767

3

[Fabry nephropathy in a female with superposed IgA glomerulonephritis].

Pisani A, Sessa A, Sabbatini M, Andreucci MV, Fusco C, Balletta M, Cianciaruso B. Pisani A, et al. Among authors: andreucci mv. G Ital Nefrol. 2005 Jul-Aug;22(4):385-9. G Ital Nefrol. 2005. PMID: 16267800 Italian.

4

Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.

Pisani A, Spinelli L, Sabbatini M, Andreucci MV, Procaccini D, Abbaterusso C, Pasquali S, Savoldi S, Comotti C, Cianciaruso B. Pisani A, et al. Among authors: andreucci mv. Am J Kidney Dis. 2005 Jul;46(1):120-7. doi: 10.1053/j.ajkd.2005.03.016. Am J Kidney Dis. 2005. PMID: 15983965

5

Edema and acute renal failure.

Andreucci M, Federico S, Andreucci VE. Andreucci M, et al. Semin Nephrol. 2001 May;21(3):251-6. doi: 10.1053/snep.2001.21652. Semin Nephrol. 2001. PMID: 11320489 Review.

6

Some sodium, potassium and water changes in the elderly and their treatment.

Andreucci VE, Russo D, Cianciaruso B, Andreucci M. Andreucci VE, et al. Nephrol Dial Transplant. 1996;11 Suppl 9:9-17. doi: 10.1093/ndt/11.supp9.9. Nephrol Dial Transplant. 1996. PMID: 9050029 Review.

7

Enhancement of nitric oxide synthesis by L-arginine supplementation in renal disease: is it good or bad?

De Nicola L, Minutolo R, Bellizzi V, Andreucci M, La Verde A, Cianciaruso B. De Nicola L, et al. Miner Electrolyte Metab. 1997;23(3-6):144-50. Miner Electrolyte Metab. 1997. PMID: 9387105 Review.

8

The impact of early normalization of haematocrit by erythropoietin on renal damage in the remnant kidney model.

Bellizzi V, Sabbatini M, Fuiano G, Sansone G, Magri P, Uccello F, Andreucci M, De Nicola L, Cianciaruso B. Bellizzi V, et al. Nephrol Dial Transplant. 1998 Sep;13(9):2210-5. doi: 10.1093/ndt/13.9.2210. Nephrol Dial Transplant. 1998. PMID: 9761499

9

Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM. Russo D, et al. Am J Kidney Dis. 2001 Jul;38(1):18-25. doi: 10.1053/ajkd.2001.25176. Am J Kidney Dis. 2001. PMID: 11431176 Clinical Trial.

10

Randomized, double-blind, placebo-controlled study of arginine supplementation in chronic renal failure.

De Nicola L, Bellizzi V, Minutolo R, Andreucci M, Capuano A, Garibotto G, Corso G, Andreucci VE, Cianciaruso B. De Nicola L, et al. Kidney Int. 1999 Aug;56(2):674-84. doi: 10.1046/j.1523-1755.1999.00582.x. Kidney Int. 1999. PMID: 10432408 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters